Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrendipine/Atenolol Combination for BP Variability in Hypertension
NCT04931108Phase 4Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Sep 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nitrendipine and atenolol in hypertension (HTN) (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Ambulatory systolic blood pressure variability at 13 weeks. Status: unknown.
02
Drugs
nitrendipineatenolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04931108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04931108.